Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$146,850.00
Oct 1, 2011
A novel dopamine D2 receptor allosteric modulator: Development and commercialization of a safer more effective generation of antipsychotic drugs
$680,630.00
Oct 1, 2011
Role of AMP-activated protein kinase in regulating inflammation in obesity: implications for the treatment of insulin resistance
$219,870.00
Oct 1, 2011
Acute Rehabilitation in Critically Ill Children, a Multicentre Study
$789,839.00
Oct 1, 2011
Oscillatory networks for rhythmic timing in auditory and motor regions: Interaction, development and plasticity
$594,915.00
Oct 1, 2011
Toward Designed Antibiotics: Mechanisms and Inhibition of PEP Utilizing Enzymes
$657,828.00
Oct 1, 2011
On the development of bone quality parameters for assessing osteoporosis using peripheral quantitative computed tomography
$100,000.00
Oct 1, 2011
The Role of ADAM17 in the Pathogenesis of Diabetic Nephropathy
$99,817.00
Oct 1, 2011
Developing a tool for determining risk of peptic ulcer complications with non-steroidal anti-inflammatory drugs.
$100,000.00
Oct 1, 2011
Informing Fresh versus Old Red Cell Management (INFORM): A large simple phase III randomized controlled trial
$227,020.00
Oct 1, 2011
Role of endoplasmic reticulum (ER) stress in the development of kidney disease.